EyePoint (EYPT) Current Assets (2011 - 2026)
EyePoint (EYPT) reported Current Assets of $249.5 million for Q1 2026, down 23.7% on a YoY basis from $327.0 million in Q1 2025, and down 24.08% sequentially from $328.7 million in Q4 2025.
EyePoint (EYPT) Current Assets (2011 - 2026) Analysis & Trends
EyePoint (EYPT) has 16 years of Current Assets data on file, last reported at $249.5 million in Q1 2026.
- For the quarter ending Q1 2026, Current Assets fell 23.7% year-over-year to $249.5 million; the trailing twelve-month figure through Mar 2026 stood at $249.5 million (down 23.7% YoY), and the FY2025 full-year result was $328.7 million, down 14.26% from the prior year.
- Current Assets declined to $249.5 million in Q1 2026, from $328.7 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $383.3 million in Q4 2024 to a low of $146.1 million in Q1 2023.
- A 5-year average of $250.0 million and a median of $249.5 million in 2026 frame the typical range for Current Assets.
- Across the five-year window, Current Assets plunged 33.5% in 2023 and soared 117.52% in 2024, its largest moves.
- Tracing EYPT's Current Assets over 5 years: stood at $172.8 million in 2022, then surged by 99.53% to $344.8 million in 2023, then gained by 11.17% to $383.3 million in 2024, then declined by 14.26% to $328.7 million in 2025, then declined by 24.08% to $249.5 million in 2026.
- Business Quant data shows EYPT's Current Assets at $249.5 million in Q1 2026, $328.7 million in Q4 2025, and $216.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 289.93 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 73.04 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 6.60 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 35.73 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 11.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 18.21 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 521.86 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 8.07 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.97 Bn |
| 10 | EyePoint | 358.61 Mn | 136.07 Mn | 168,000.00 | 249.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 249.50 Mn |
| Dec 31, 2025 | 328.66 Mn |
| Sep 30, 2025 | 216.11 Mn |
| Jun 30, 2025 | 265.25 Mn |
| Mar 31, 2025 | 326.98 Mn |
| Dec 31, 2024 | 383.31 Mn |
| Sep 30, 2024 | 268.55 Mn |
| Jun 30, 2024 | 294.93 Mn |
| Mar 31, 2024 | 317.71 Mn |
| Dec 31, 2023 | 344.80 Mn |
| Sep 30, 2023 | 150.16 Mn |
| Jun 30, 2023 | 167.12 Mn |
| Mar 31, 2023 | 146.06 Mn |
| Dec 31, 2022 | 172.81 Mn |
| Sep 30, 2022 | 192.10 Mn |
| Jun 30, 2022 | 205.87 Mn |
| Mar 31, 2022 | 219.63 Mn |
| Dec 31, 2021 | 237.75 Mn |
| Sep 30, 2021 | 141.78 Mn |
| Jun 30, 2021 | 151.83 Mn |